GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RAMM Pharma Corp (XCNQ:RAMM) » Definitions » EV-to-FCF

RAMM Pharma (XCNQ:RAMM) EV-to-FCF : -0.29 (As of Apr. 09, 2025)


View and export this data going back to 2019. Start your Free Trial

What is RAMM Pharma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, RAMM Pharma's Enterprise Value is C$1.17 Mil. RAMM Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2024 was C$-4.05 Mil. Therefore, RAMM Pharma's EV-to-FCF for today is -0.29.

The historical rank and industry rank for RAMM Pharma's EV-to-FCF or its related term are showing as below:

XCNQ:RAMM' s EV-to-FCF Range Over the Past 10 Years
Min: -28.05   Med: -2.31   Max: 0.31
Current: -0.29

During the past 7 years, the highest EV-to-FCF of RAMM Pharma was 0.31. The lowest was -28.05. And the median was -2.31.

XCNQ:RAMM's EV-to-FCF is ranked worse than
100% of 548 companies
in the Drug Manufacturers industry
Industry Median: 24.07 vs XCNQ:RAMM: -0.29

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-09), RAMM Pharma's stock price is C$0.015. RAMM Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 was C$-0.138. Therefore, RAMM Pharma's PE Ratio (TTM) for today is At Loss.


RAMM Pharma EV-to-FCF Historical Data

The historical data trend for RAMM Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RAMM Pharma EV-to-FCF Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
EV-to-FCF
Get a 7-Day Free Trial -5.61 -9.45 -2.53 -0.29 -0.14

RAMM Pharma Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -0.54 -1.10 -0.24 -0.14

Competitive Comparison of RAMM Pharma's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RAMM Pharma's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's EV-to-FCF falls into.


;
;

RAMM Pharma EV-to-FCF Calculation

RAMM Pharma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1.165/-4.045
=-0.29

RAMM Pharma's current Enterprise Value is C$1.17 Mil.
RAMM Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-4.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RAMM Pharma  (XCNQ:RAMM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

RAMM Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.015/-0.138
=At Loss

RAMM Pharma's share price for today is C$0.015.
RAMM Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.138.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


RAMM Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of RAMM Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


RAMM Pharma Business Description

Traded in Other Exchanges
N/A
Address
82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue primarily from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of revenue from Uruguay.
Executives
Jackie Peter Burnett 10% Security Holder, Director, Senior Officer
Armando Gabriel Blankleider Director

RAMM Pharma Headlines

No Headlines